Position in CYTK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$10,052
+$2,275 QoQ
Shares Held
118
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 61 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026High Note Wealth, LLC holds $155,871 across 9 Biotechnology names. CYTK ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
1,600 | $75,264 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95 | $47,189 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17 | $10,600 | |
| 4 | CYTK |
Cytokinetics Inc
This page
|
118 | $10,052 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
82 | $6,688 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12 | $3,612 | |
| 7 | CNTN |
Canton Strategic Holdings, Inc.
|
600 | $1,692 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3 | $561 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,052 | 118 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,777 | 118 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,497 | 118 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,199 | 131 | Shares | Sole | 2025-11-04 | |
| 2025-03-31 | $3,175 | 79 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,458 | 31 | Shares | Sole | 2025-04-01 | |
| No filing history on record for this holder in this stock. | ||||||